Published
David Reardon, MD, as Clinical Director of the Center for Neuro-oncology at the Dana Farber Cancer Institute, USA, talks us through the potential and scope new innovations in bespoke cell and gene therapy for solid tumors, such as with the CliniMACS Prodigy® Platform, can empower a new wave of patient care.
- Categoria
- Oncology
Commenta per primo questo video.
Prossimo
-
09:56
How Google & mRNA Technology Could Lead to a Cancer Cure | Personalised vaccine for all..
-
08:33
Pioneering Cancer Research | Prof. Luhai Wang's Groundbreaking Work in Oncology
-
05:45
Pioneering Advances in Bladder Cancer: New Drug Classes, Biomarkers, and Treatment Models
-
05:42
क्या Immune System Cancer को ख़त्म कर सकता है? | Immune System vs Cancer! | Dr Praveen Kammar, Mumbai
-
19:09
Prostate Cancer Awareness Month: The Urologist and Oncologist Perspectives
-
04:44
Echo for the Next Pulse: Pioneering new frontiers in ECPR with SAMU de Paris
-
04:21
Oncology Therapies Shifting Toward Biomarkers and Precision Medicine Therapies | PBMI 2025
-
04:03
Personalised chemo for African patients
-
05:33
Cardiology Challenges and Solutions: Leaders Share Their Perspectives
-
04:52
Personalised treatment in childhood cancer: A journey through ???????????????? fusion testing
-
09:07
Cardiology for Beginners: Basics of Heart Sounds and Murmurs (with examples)
-
13:45
How to Become a Cardiologist | Cardiac Electrophysiologist
-
04:14
V 00592 Cardiology Fellowship Video Dr Vranian V5
-
05:17
Cardiology Fellowship at SIU Medicine
-
04:15
Cardiology Fellowship Program at Danbury Hospital
-
05:49
Practice Question: Cardiology #1, USMLE Step 1, COMLEX Level 1
-
04:07
Dr. Muhammed Raza on advice for Fellows interested in Interventional Cardiology
-
07:36
Congenital Heart Disease – Cardiology | Lecturio
-
05:18
Cardiology Fellowship at IU School of Medicine
-
04:36
What are different types of Cardiology Tests | SPS Hospitals
